Your preferences have been updated successfully.
Top 30 Lists
Pharmastandard International Leads $20M Series C In Avelas Biosciences
Avelas Biosciences, a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced it has completed a Series C financing which raised $20 million.
READ FULL INVESTMENT ARTICLE
In this article